Home - Products - Others - Other Targets - [Tyr65,Phe67]-C5a (65-74) (human)

[Tyr65,Phe67]-C5a (65-74) (human)

CAS No. 157952-15-3

[Tyr65,Phe67]-C5a (65-74) (human)( ——— )

Catalog No. M42106 CAS No. 157952-15-3

[Tyr65,Phe67]-C5a (65-74) (human)

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    [Tyr65,Phe67]-C5a (65-74) (human)
  • Note
    Research use only, not for human use.
  • Brief Description
    [Tyr65,Phe67]-C5a (65-74) (human)
  • Description
    [Tyr65,Phe67]-C5a (65-74) (human)
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    157952-15-3
  • Formula Weight
    1244.45
  • Molecular Formula
    C55H85N15O16S
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Spectinomycin sulfat...

    Spectinomycin sulfate hydrate is a broad-spectrum antibiotic and inhibits the growth of a variety of gram-positive and gram-negative organisms. Spectinomycin sulfate hydrate acts by selectively targeting to the bacterial ribosome and interrupting protein synthesis. Spectinomycin sulfate hydrate is also a noncompetitive inhibitor of td intron RNA with an Ki value of 7.2 mM-.

  • Concizumab

    Concizumab is an anti-TFPI monoclonal antibody (IgG4 type) that selectively binds to the Kunitz protease inhibitor (KPI) 2 domain of TFPI, blocking its interaction with the FXa active site.

  • Antho-Rwamide I

    Antho-rwamide I is a neuropeptide that can be isolated from the sea anemone Anthopleura elegantissima. Antho-rwamide I is resistant to nonspecific aminopeptidases, which increases the stability of the peptide after neuronal release.